Loading…
The insulin–melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus)
Aims/hypothesis It is well documented that melatonin influences insulin secretion mediated by G-protein-coupled melatonin receptor isoforms MT1 and MT2, which are present in rat and human pancreatic islets, as well as in rat insulinoma cells. Recent investigations have proven that hyperinsulinaemic...
Saved in:
Published in: | Diabetologia 2011-07, Vol.54 (7), p.1831-1840 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Aims/hypothesis
It is well documented that melatonin influences insulin secretion mediated by G-protein-coupled melatonin receptor isoforms MT1 and MT2, which are present in rat and human pancreatic islets, as well as in rat insulinoma cells. Recent investigations have proven that hyperinsulinaemic Goto–Kakizaki (GK) rats, which are a rat model of type 2 diabetic rats, and humans have decreased melatonin plasma levels, whereas a streptozotocin-induced rat model of diabetes developed reduced insulin levels combined with increased melatonin levels.
Methods
Plasma levels of glucose, insulin and melatonin as well as RNA expression of pineal
Aanat
,
Hiomt
(also known as
Asmt
), insulin receptor, adrenoceptor
β
1 and the clock genes
Per1
and
Bmal1
(also known as
Arntl
) were determined in male and female LEW.1AR1-
iddm
rats as well as in insulin-substituted LEW.1AR1-
iddm
rats.
Results
Severe hypoinsulinaemia in diabetic LEW.1AR1-
iddm
rats was associated with decreased body weight and increased melatonin plasma levels combined with mainly elevated expression of
Aanat
,
Hiomt
, pineal insulin receptor and adrenoceptor
β
1. The changes were normalised by insulin substitution. Diurnal profiles of plasma melatonin and of antagonistic clock genes
Per1
and
Bmal1
were maintained in diabetic and insulin-substituted rats.
Conclusions/interpretation
The assumed causal relation between elevated melatonin and reduced insulin levels in LEW.1AR1-
iddm
rats is supported by the observation that insulin substitution normalised these changes. Further support for this interpretation comes from the observation that in GK rats an increase of plasma insulin was combined with a decrease of plasma noradrenaline (norepinephrine), the most important activator of melatonin synthesis. These relationships between the noradrenergic and insulin pathway support the existence of melatonin–insulin antagonism. |
---|---|
ISSN: | 0012-186X 1432-0428 |
DOI: | 10.1007/s00125-011-2138-0 |